Amerisource Health Services LLC recalls Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose (…

Recall date

March 16, 2026

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0418-2026

FDA classification

Class II

Brand / firm

Amerisource Health Services LLC

Sold / distributed

U.S. Nationwide

Why it was recalled

Failed tablet specifications.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.